GlassScriptPhysician profile
Vontrese Simpson
NPI 1275077372
$912.17
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $406 · 2022: $213 · 2023: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $208 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $208.44 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $265.48 | 2021-2022 | |
| Astellas Pharma US INC | $133.95 | 2023 | Veozah, Myrbetriq |
| Myovant Sciences INC. | $75.79 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $72.50 | 2023 | Myfembree |
| Organon LLC | $69.15 | 2021-2023 | Nexplanon |
| Therapeuticsmd, INC. | $67.79 | 2021 | |
| Mylan Pharmaceuticals INC. | $63.79 | 2021-2022 | |
| Hologic Sales and Service, LLC | $50.63 | 2023 | Aptima |
| Avion Pharmaceuticals | $48.87 | 2021-2022 | |
| Smith+Nephew, INC. | $18.83 | 2023 | Pico 14, Pico 7 |
| Scynexis, INC. | $17.25 | 2022 | |
| Exeltis, USA INC. | $14.19 | 2022 | |
| Mayne Pharma Commercial LLC | $13.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vontrese Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.